Article
Pseudolaric acid B circumvents multidrug resistance phenotype in human gastric cancer SGC7901/ADR cells by downregulating Cox-2 and P-gp expression.
Cell biochemistry and biophysics - 1 Jan 2015
Yu Fei, Li Kai, Chen Suning, Liu Yunpeng, Li Yan
Abstract excerpt
Multidrug resistance (MDR) is a challenging issue in the treatment of gastric cancer. Pseudolaric acid B is a new diterpene acid compound isolated from pseudolarix, which has been found to have anti-tumor activities in recent studies. The purpose of the present study was to evaluate the effects of pseudolaric acid B in an MDR gastric cancer cell line and elucidate the possible underlying mechanisms of action....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
